[#item_full_content] The U.S. Department of Justice (DOJ) has enacted a significant change in federal drug classification, impacting the medical cannabis rescheduling. On April 22, 2026, Acting Attorney General…
Read More
[#item_full_content] The U.S. Department of Justice (DOJ) has enacted a significant change in federal drug classification, impacting the medical cannabis rescheduling. On April 22, 2026, Acting Attorney General…
Read More